Form 424B3 Elevance Health, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Elevance (ELV) PT Lowered to $548 at JPMorgan
October 23, 2024 4:13 PM EDTJPMorgan analyst Lisa Gill lowered the price target on Elevance (NYSE: ELV) to $548.00 (from $655.00) while maintaining a Overweight rating.
The analyst comments "ELV owns the most recognizable national brand and operates with leading market share in its commercial licensed BCBS markets.... More
